MétaCan
Menu
Back to cohort
Record W2107578540 · doi:10.1158/0008-5472.can-10-1907

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Implications for Risk Prediction

2010· article· en· W2107578540 on OpenAlexfundno aff
Antonis C. Antoniou, Jonathan Beesley, Lesley McGuffog, Olga M. Sinilnikova, Sue Healey, Susan L. Neuhausen, Yuan Chun Ding, Timothy R. Rebbeck, Jeffrey N. Weitzel, Henry T. Lynch, Claudine Isaacs, Patricia A. Ganz, Gail E. Tomlinson, Olufunmilayo I. Olopade, Fergus J. Couch, Xianshu Wang, Noralane M. Lindor, V. Shane Pankratz, Paolo Radice, Siranoush Manoukian, Bernard Peissel, Daniela Zaffaroni, Monica Barile, Alessandra Viel, Anna Allavena, Valentina Dall’Olio, Paolo Peterlongo, Csilla I. Szabo, Michal Zikán, Kathleen Claes, Bruce Poppe, Lenka Foretová, Mark H. Greene, Gad Rennert, Flavio Lejbkowicz, Gord Glendon, Hilmi Özçelik, Irene L. Andrulis, Mads Thomassen, Anne‐Marie Gerdes, Lone Sunde, Dorthe Gylling Crüger, Uffe Birk Jensen, Maria A. Caligo, Eitan Friedman, Bella Kaufman, Yael Laitman, Roni Milgrom, Maya Dubrovsky, Shimrit Cohen, Åke Borg, Helena Jernström, Annika Lindblom, Johanna Rantala, Marie Stenmark-Askmalm, Beatrice Melin, Susan M. Domchek, Anna Jakubowska, Jan Lubiński, Tomasz Huzarski, Ana Osório, Adriana Lasa, M. Durán, María‐Isabel Tejada, Javier Benı́tez, Ute Hamann, Mieke Kriege, Rob B. van der Luijt, Christi J. van Asperen, Peter Devilee, E.J. Meijers-Heijboer, Marinus J. Blok, Cora M. Aalfs, Frans B.L. Hogervorst, Matti A. Rookus, Margaret Cook, Clare Oliver, Debra Frost, Don Conroy, D. Gareth Evans, Fiona Lalloo, Gabriella Pichert, Rosemarie Davidson, Trevor Cole, Jackie Cook, Joan Paterson, Shirley Hodgson, Patrick J. Morrison, Mary Porteous, Lisa Walker, Michael J. Kennedy, Huw Dorkins, Susan Peock, Andrew K. Godwin, Dominique Stoppa‐Lyonnet, Antoine De Pauw, Sylvie Mazoyer, Valérie Bonadona, Christine Lasset, Hélène Dreyfus, Dominique Leroux, Agnès Hardouin, Pascaline Berthet, Laurence Faivre, Catherine Loustalot, Tetsuro Noguchi, Hagay Sobol, Étienne Rouleau, Catherine Noguès, Marc Frénay, Laurence Venat‐Bouvet, John L. Hopper, Mary B. Daly, Mary Beth Terry, Esther M. John, Saundra S. Buys, Yosuf Yassin, Alexander Miron, David E. Goldgar, Christian F. Singer, Anne Catharina Dressler, Daphne Gschwantler‐Kaulich, Georg Pfeiler, Thomas van Overeem Hansen, Lars Jønson, Bjarni A. Agnarsson, Tomas Kirchhoff, Kenneth Offit, Vincent J. Devlin, Ana Dutra-Clarke, Marion Piedmonte, Gustavo C. Rodriguez, Katie Wakeley, John F. Boggess, Jack Basil, Peter E. Schwartz, Stephanie V. Blank, Amanda E. Toland, Marco Montagna, Cinzia Casella, Evgeny Imyanitov, Laima Tihomirova, Ignacio Blanco, Conxi Lázaro, Susan J. Ramus, Lara Sucheston, Beth Y. Karlan, Jenny Gross, Rita K. Schmutzler, Barbara Wappenschmidt, Christoph Engel, Alfons Meindl, Magdalena Lochmann, Norbert Arnold, Simone Heidemann, Raymonda Varon-Mateeva, Dieter Niederacher, Christian Sutter, Helmut Deißler, Dorothea Gadzicki, Sabine Preisler‐Adams, Karin Kast, Ines Schönbuchner, Trinidad Caldés, Miguel de la Hoya, Kristiina Aittomäki, Heli Nevanlinna, Jacques Simard, Amanda B. Spurdle, Helene Holland, Radka Platte, Georgia Chenevix‐Trench, Douglas F. Easton

Bibliographic record

VenueCancer Research · 2010
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBRCA gene mutations in cancer
Canadian institutionsnot available
FundersNational Cancer InstituteNIH Office of the DirectorBerrikuntza + Ikerketa + Osasuna Eusko FundazioaNorris Cotton Cancer CenterUniversity of California, IrvineNational Institutes of HealthIstituto Oncologico VenetoFox Chase Cancer CenterAlleanza Contro il CancroUppsala UniversitetFondazione Italiana per la Ricerca sul CancroUniversità degli Studi di TorinoRadboud Universitair Medisch Centrumlékařská fakulta Univerzity KarlovyLeids Universitair Medisch CentrumAssociazione Italiana per la Ricerca sul CancroMinisterio de Ciencia e InnovaciónCancer Research UKKWF KankerbestrijdingUniversity of PennsylvaniaUniversiteit GentIsrael Cancer AssociationLunds UniversitetVlaamse regeringSahlgrenska UniversitetssjukhusetErasmus Medisch CentrumVrije Universiteit AmsterdamMayo ClinicGrantová Agentura České RepublikyInstitut National de la Santé et de la Recherche MédicaleUniversitair Medisch Centrum GroningenRoyal Marsden NHS Foundation TrustHuntsman Cancer InstituteUniversiteit LeidenCentre National de la Recherche ScientifiqueDeutsches KrebsforschungszentrumUniverzita Karlova v PrazeRadboud UniversiteitOhio State UniversityCanadian Institutes of Health ResearchFonds Wetenschappelijk OnderzoekDivision of Cancer Epidemiology and Genetics, National Cancer InstituteMinistero della SaluteAkademiska SjukhusetCancer Care OntarioVlaamse Liga Tegen KankerBreast Cancer Research Foundation
KeywordsBreast cancerSingle-nucleotide polymorphismGenotypeAlleleCancerOncologyMedicineGeneticsInternal medicineBiologyGene

Abstract

fetched live from OpenAlex

The known breast cancer susceptibility polymorphisms in FGFR2, TNRC9/TOX3, MAP3K1, LSP1, and 2q35 confer increased risks of breast cancer for BRCA1 or BRCA2 mutation carriers. We evaluated the associations of 3 additional single nucleotide polymorphisms (SNPs), rs4973768 in SLC4A7/NEK10, rs6504950 in STXBP4/COX11, and rs10941679 at 5p12, and reanalyzed the previous associations using additional carriers in a sample of 12,525 BRCA1 and 7,409 BRCA2 carriers. Additionally, we investigated potential interactions between SNPs and assessed the implications for risk prediction. The minor alleles of rs4973768 and rs10941679 were associated with increased breast cancer risk for BRCA2 carriers (per-allele HR = 1.10, 95% CI: 1.03-1.18, P = 0.006 and HR = 1.09, 95% CI: 1.01-1.19, P = 0.03, respectively). Neither SNP was associated with breast cancer risk for BRCA1 carriers, and rs6504950 was not associated with breast cancer for either BRCA1 or BRCA2 carriers. Of the 9 polymorphisms investigated, 7 were associated with breast cancer for BRCA2 carriers (FGFR2, TOX3, MAP3K1, LSP1, 2q35, SLC4A7, 5p12, P = 7 × 10(-11) - 0.03), but only TOX3 and 2q35 were associated with the risk for BRCA1 carriers (P = 0.0049, 0.03, respectively). All risk-associated polymorphisms appear to interact multiplicatively on breast cancer risk for mutation carriers. Based on the joint genotype distribution of the 7 risk-associated SNPs in BRCA2 mutation carriers, the 5% of BRCA2 carriers at highest risk (i.e., between 95th and 100th percentiles) were predicted to have a probability between 80% and 96% of developing breast cancer by age 80, compared with 42% to 50% for the 5% of carriers at lowest risk. Our findings indicated that these risk differences might be sufficient to influence the clinical management of mutation carriers.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.498
Threshold uncertainty score0.992

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0020.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0010.001
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.022
GPT teacher head0.362
Teacher spread0.340 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations184
Published2010
Admission routes1
Has abstractyes

Explore more

Same venueCancer ResearchSame topicBRCA gene mutations in cancerFrench-language works237,207